abstract |
The invention relates to cyclic ureas of compounds of formula (I), which are suited for use as inhibitors of metalloproteases, particularly of ADAMTS proteases and TNF-a converting enzymes. The invention also relates to a method for producing these compounds and to the use thereof for treating diseases such as osteoarthrosis and rheumatoid arthritis. |